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ABSTRACT
Objective: To compare health service cost and length
of stay between a traditional and an accelerated
diagnostic approach to assess acute coronary
syndromes (ACS) among patients who presented to the
emergency department (ED) of a large tertiary hospital
in Australia.
Design, setting and participants: This historically
controlled study analysed data collected from two
independent patient cohorts presenting to the ED with
potential ACS. The first cohort of 938 patients was
recruited in 2008–2010, and these patients were
assessed using the traditional diagnostic approach
detailed in the national guideline. The second cohort of
921 patients was recruited in 2011–2013 and was
assessed with the accelerated diagnostic approach
named the Brisbane protocol. The Brisbane protocol
applied early serial troponin testing for patients at 0
and 2 h after presentation to ED, in comparison with 0
and 6 h testing in traditional assessment process. The
Brisbane protocol also defined a low-risk group of
patients in whom no objective testing was performed.
A decision tree model was used to compare the
expected cost and length of stay in hospital between
two approaches. Probabilistic sensitivity analysis was
used to account for model uncertainty.
Results: Compared with the traditional diagnostic
approach, the Brisbane protocol was associated with
reduced expected cost of $1229 (95% CI −$1266 to
$5122) and reduced expected length of stay of 26 h
(95% CI −14 to 136 h). The Brisbane protocol allowed
physicians to discharge a higher proportion of low-risk
and intermediate-risk patients from ED within 4 h (72%
vs 51%). Results from sensitivity analysis suggested
the Brisbane protocol had a high chance of being cost-
saving and time-saving.
Conclusions: This study provides some evidence of
cost savings from a decision to adopt the Brisbane
protocol. Benefits would arise for the hospital and for
patients and their families.
INTRODUCTION
Chest pain is a principal reason for adult
emergency department (ED) visits1 with the
most common cause being acute coronary
syndromes (ACS) including acute myocardial
infarction (AMI) and unstable angina pec-
toris (UAP). Yet after thorough investigation
most patients have non-cardiac conditions
such as musculoskeletal pain or gastrointes-
tinal causes for chest discomfort. In 2007–
2008, 5.5 million people in the USA pre-
sented to EDs with chest pain and only 13%
were diagnosed with ACS.2
Current management of patients with pos-
sible ACS in Australia arises from the
National Heart Foundation and Cardiac
Society of Australia and New Zealand
Guidelines.3 Patients are stratified into
low-risk, intermediate-risk and high-risk cat-
egories based on clinical features, ECG and
troponin test results over a minimum of 6 h
when using a sensitive troponin assay.
Low-risk patients can be safely discharged.
High-risk patients require admission to hos-
pital and intensive management.
Intermediate-risk patients form the largest
group and further objective diagnostic
testing to identify coronary artery disease
(CAD) are required. The costs to health
Strengths and limitations of this study
▪ This is the first study to report the changes to
length of stay and cost from adopting an acceler-
ated diagnostic approach for unspecified chest
pain in Australian emergency departments.
▪ It was a large study that prospectively collected
data on costs and outcomes.
▪ A decision tree model was developed to compare
outcomes of the two approaches using realistic
and clinically relevant patient pathways.
▪ Probabilistic sensitive analysis was used to
account for uncertainties.
▪ This is an observational study and differences
were found between the two cohorts that may
confound differences due to the two approaches.
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services and patient outcomes from these guidelines
were described in a recent Australian study.4
The National Emergency Access Target (NEAT) was
introduced in 2011 in Australia as part of the National
Partnership Agreement on Improving Public Hospital
Services.5 It requires 90% of all presentations to the ED
to be discharged, admitted to hospital or transferred to
another hospital for treatment within 4 h. This target
requires patients to be processed faster in the ED
setting, and with the current guidelines requiring
delayed troponin sampling, all patients with possible
cardiac chest pain are steered towards admission to
hospital.
Accelerated diagnostic protocols (ADPs) that risk
stratify individuals within 2–3 h have recently been
trialled.6–10 A large proportion of patients can be classi-
fied as low risk and rapidly referred for objective
testing.6–8 11 A study reporting on the implementation
of the accelerated protocol found that average ED
length of stay was reduced in the group of patients
deemed low risk and health outcomes were maintained.9
Ongoing improvements in the assessment process of
ED patients with chest pain have occurred and are in
clinical use.12
A novel method for the assessment of ED patients
with chest pain, the Brisbane protocol, was developed
prior to the advent of NEAT in Australia. It was a
clinician-led initiative in response to our improved clin-
ical understanding of the impact of improvements in
biomarker (troponin) assays and the unnecessary
delays in testing during patient assessment. We believed
that we could safely accelerate the assessment process
and therefore designed the Brisbane protocol. This
study compares the cost of managing patients for ACS
who present to the ED under two competing configura-
tions of health services: the traditional guidelines-based
approach3 and the Brisbane protocol. Detailed clinical
outcomes of patients were not reported as this study
focused on health economic outcomes of two diagnostic
approaches.
METHODS
Data collection
This was an observational study that analysed data from
two separate prospective patient cohorts presenting to
the ED of a large tertiary hospital in Australia with pos-
sible ACS. The first patient cohort of 938 consenting
patients was recruited in 2008–2010, and these patients
were assessed using the traditional diagnostic approach
detailed in the national guidelines.3 The main reason
for recruiting the first cohort was to report on costs to
health services and patient outcomes from applying the
national guidelines.4 In this study, the first patient
cohort was a baseline comparison group to assess the
changes in the ED after the Brisbane protocol was
designed and implemented. The second patient cohort
(n=921) was recruited and assessed with the Brisbane
protocol in 2011–2013. Process of care for patients
managed by the traditional approach and the Brisbane
protocol is shown in figure 1.
Patients were recruited for both cohorts between 8:00
and 17:00 and were included if they were aged
≥18 years, presented to the ED with at least 5 min of
chest pain suggestive of ACS and were being investigated
for ACS. In accordance with the American Heart
Association case definitions,13 pain suggestive of ACS
includes acute chest, epigastric, neck, jaw or arm pain,
or discomfort or pressure without an apparent non-
cardiac source. Research staff identified all eligible
patients using the ED admissions database and in collab-
oration with the treating clinicians. Patients were
excluded if (1) there was a clear non-ACS cause for
their symptoms, (2) they were unwilling or unable to
provide informed consent such as a language barrier,
(3) staff considered that recruitment was inappropriate,
such as terminal illness, (4) they were transferred from
another hospital, (5) they were pregnant, (6) they were
recruited to the study within the previous 45 days or (7)
they were unable or unwilling to be contacted after dis-
charge. Perceived high risk was not an exclusion criter-
ion. Consecutive eligible cases were included. The
number of patients approached and the number of
patients excluded for each reason in the first cohort
have been published.4 In the second cohort, 1438
patients were approached. Excluded patients are as
follows: 289 declined or were unable to consent, 72 were
identified >2 h after presentation, 39 were interhospital
transfers, 17 were pregnant and 100 did not have cost
data. Patients who were not eligible, who refused
consent and who presented outside of recruitment
periods were managed according to the historical
guideline-based process of assessment.
Research nurses collected data on presentation date,
admission date, discharge date, risk stratification and
exercise stress test (EST) results. Total costs including
the cost of the ED visit and any inpatient costs were
extracted from a linked administrative database. Thirty
days after initial attendance, research nurses conducted
telephone follow-up and medical record review for the
diagnosis of ACS. Information was obtained from the
patient and from hospital databases about whether there
had been any cardiac events or investigations, or contact
with any healthcare providers, during the 30-day period.
All follow-up information was verified through contact
with the healthcare provider, and original copies of
medical records and cardiac investigation results
were obtained. Relevant investigations included
EST, stress echocardiography, myocardial perfusion scan-
ning, coronary CT angiography or coronary angiography.
The 30-day clinical outcomes were adjudicated inde-
pendently by at least one of two local cardiologists
using predefined standardised reporting guidelines.14
Cardiologists had knowledge of all clinical information
collected within a 30-day period. For both cohorts, this
included all hospital medical records, public and private
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investigations, details provided by general practitioners
and specialists seen within 30 days after discharge and by
telephone contact with patients. In the first cohort, a
second cardiologist conducted a blind review of all ACS
cases and a random sample of 10% of non-ACS cases. In
cases of disagreement, end points were agreed by con-
sensus. This was achieved for all end points. For the
second cohort, a single cardiologist completed end point
adjudication as the second adjudication of the outcomes
has not occurred at this point in time. The clinical out-
comes will be fully reported once this second adjudica-
tion has occurred. Diagnosis of AMI and UAP was based
on accepted international standards as described
previously.15
Decision tree model
A decision tree model was developed to compare costs
and health outcomes of the two approaches using real-
istic and clinically relevant patient pathways. The
model enabled the change to costs and health out-
comes to be clearly presented, and the uncertainties
in the data to be included. The purpose of the model
was to inform a decision between the Brisbane
Protocol and the traditional approach. The traditional
approach based on national guidelines3 is shown in
figure 2. All non-high-risk patients were initially strati-
fied into intermediate-risk and low-risk categories
based on clinical features, ECG findings and troponin
results obtained on presentation. Ongoing clinical
assessment and repeat ECG and troponin testing were
performed 6 h later. Low-risk patients were discharged
and costs arising from the index presentation were
included. After serial troponin and ECG testing 6 h
after presentation were normal, patients in the
intermediate-risk group were referred for EST;
however, owing to clinical reasons, some
intermediate-risk patients did not have this test. If the
EST result was positive, patients were further stratified
to high risk and admitted to an inpatient bed. If nega-
tive, patients were considered low risk and discharged
home. Patients with an equivocal EST and who were
discharged within 24 h were defined as low risk, and
those discharged >24 h were defined as high risk.
Patients who did not have an EST were either directly
admitted to an inpatient bed or discharged home
after appropriate management in the ED and/or ED
short stay unit. A small number of patients left against
medical advice before treatment started.
Figure 1 Process of care for patients with possible acute coronary syndromes under the traditional approach and the Brisbane
protocol.
Cheng Q, et al. BMJ Open 2016;6:e009746. doi:10.1136/bmjopen-2015-009746 3
Open Access
group.bmj.com on February 28, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
A fundamental change in the new assessment process
was the introduction of early serial troponin testing at 0
and 2 h after presentation for low-risk and
intermediate-risk patients, in comparison with the trad-
itional 0 and 6 h testing. The alternate Brisbane proto-
col is shown in figure 3. High-risk patients were initially
identified and managed according to the traditional
approach since the Brisbane protocol was designed for
low-risk and intermediate-risk patients. All non-high-risk
patients were then assessed using the Brisbane
protocol. Those under 40 years of age without diabetes
or renal impairment were defined as Brisbane protocol-
low risk, while the rest were classified as Brisbane
protocol-intermediate risk. Patients in the Brisbane
protocol-intermediate-risk group were referred for EST.
As this was a pragmatic study design, some patients from
the Brisbane protocol-low-risk group were also referred
for EST based on individual patient characteristics. If
the EST was positive, the patient was considered high
risk and admitted to an inpatient bed. If negative,
patients were discharged and any problems within
30 days were included. If equivocal and discharged
within 24 h, patients were defined as low risk. If they
were admitted >24 h, they were categorised as high risk.
Patients who were not referred for an EST were either
admitted to an inpatient bed or discharged home after
appropriate management in the ED/ED short stay unit.
Again, only a small number of patients left against
medical advice.
The decision trees are designed to summarise
expected costs and hospital length of stay under the
traditional approach and the Brisbane protocol to give a
system-level picture of the costs and benefits that would
be useful to a high-level decisionmaker. If there are dif-
ferences in the number of deaths, this is also shown
quantitatively by the decision tree. Clinicians working in
the ED validated the structure of the decision tree
model prior to data analysis.
Data analysis
Age, gender, risk factors and medical history were com-
pared across the two cohorts. The primary outcomes are
health service cost and length of stay in hospital and
were compared using the decision tree model. As the
Brisbane protocol is for low-risk to intermediate-risk
patients, all high-risk patients were managed according
to the current National Heart Foundation and Cardiac
Society of Australia and New Zealand Guidelines3 and
were excluded from the analysis. The proportion of
patients discharged from ED within 4 h was compared to
show if the Brisbane protocol was associated with
improved performance against the NEAT target.
This was a historically controlled study without
random assignment; hence, there may have been
Figure 2 Traditional approach pathways.
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differences between the two cohorts at baseline. We
used multiple variable regression models to test if base-
line characteristics were associated with risk stratification,
cost, length of stay in hospital and proportion of patients
discharged from ED within 4 h (in IBM SPSS Statistics
21). Results of regression analysis are provided in the
online supplementary material. To test whether more
patients risk stratified to low risk was due to baseline
characteristics or the Brisbane protocol, we used binary
logistic regression as the new stratification only works on
low-risk and intermediate-risk patients. The results
suggest that it was the Brisbane protocol that was mainly
responsible for the change in risk stratification, so any
difference in baseline characteristics should not have
greatly impacted risk stratification. We also used linear
regression to test if baseline characteristics had any
impact on cost and length of stay for patients who
moved through the same pathway in the decision tree
model (eg, patients who were classed as intermediate
risk, had EST and had negative EST outcome). The
results suggested little impact from baseline character-
istics on total costs and length of stay in hospital. This is
probably because patients who moved through the same
pathway in the decision tree were relatively homoge-
neous. Thus, baseline differences between patients had
less potential to influence costs and length of stay.
Figure 3 Brisbane protocol pathways.
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Therefore, we did not adjust decision tree model inputs
by baseline characteristics.
Differences between two cohorts at baseline did influ-
ence the proportion of patients discharged from ED
within 4 h. To account for this, we used iterative post-
stratification to match the marginal distributions of the
traditional approach cohort to the Brisbane protocol
cohort. The variables matched were age (10-year bands),
gender, prior myocardial infarction (MI), prior angina,
prior CAD, prior arrhythmia, prior congestive heart
failure (CHF), prior hypertension, prior dyslipidaemia
and prior family CAD. We then calculated the per cent
discharged within 4 h between the two cohorts using the
post-stratification weights and compared this with an
unweighted per cent. We used the ‘rake’ function in the
‘survey’ library in R.16
Updating the decision tree with information
The probabilities associated with the events at each cir-
cular chance node in the decision trees were derived
from the two patient cohorts. The estimated probabil-
ities were the risk of patients having low or intermediate
risk, undergoing EST, having positive, negative or
equivocal EST results, being admitted to inpatient ward
or being discharged. Prior β distributions that can only
take values between 0 and 1 were used to model the
probabilities and the uncertainty.
The costs incurred for the ED and inpatient wards
were retrieved from each patient’s hospital administra-
tion record that had been linked to the primary patient
data. ED costs that include a fixed cost and an activity-
based component were based on triage categories of
clinical urgency.4 Inpatient costs were derived from
procedure-related Australian Refined Diagnosis Related
Group reimbursement codes used for activity-based
funding.4 These costs were summed for each individual.
For patients who moved through a common pathway in
the decision tree, the median cost values were calculated
to inform the cost outcome of that path. The costs of
adverse events that might occur after discharge were not
included. A prior γ distribution was fitted to these data
to capture the inherent skew in cost data.17 Costs from
2008 to 2012 were adjusted by an inflation rate of 3.4%
per year to equal 2013 prices.18 Lengths of stay in hos-
pital were derived from dates of presentation and dis-
charge and were also fitted to γ distributions.
Expected costs and lengths of stay are based on the
summation of the pathway cost and hours in hospital
weighted by the pathway probabilities. By comparing the
expected cost and length of stay of the two competing
diagnostic approaches, we defined the costs and time
spent in ED when the Brisbane protocol was used.
A probabilistic sensitivity analysis was used to account
for uncertainty in the information used in the model.
Resampling was done 10 000 times from the prior distri-
butions using Monte Carlo simulation with cost and
length of stay varying simultaneously. The probability of
an approach being optimal was derived by counting the
number of times out of 10 000 the approach had lower
costs or shorter length of hospital stay.
RESULTS
Patient characteristics
The baseline patient characteristics for both cohorts are
shown in table 1. Patients in the traditional approach
group were older and suffered more frequently from
Table 1 Baseline characteristics by cohort
Variable
Traditional
approach (n=938)
Brisbane
protocol (n=921) p Value
Age, mean (SD) 54.8 (15.1) 50.8 (12.9) <0.01
Male sex, n (%) 573 (61.1) 538 (58.4) 0.24
Risk factors n (%)
Hypertension 396 (42.2) 306 (33.2) <0.01
Dyslipidaemia 391 (41.7) 320 (34.7) <0.01
Diabetes 115 (12.3) 105 (11.4) 0.57
Family history of CAD 434 (46.3) 352 (38.3) <0.01
Current smoking 259 (27.6) 267 (29.0) 0.51
Prior medical history n (%)
Prior MI 158 (16.8) 115 (12.5) <0.01
Prior angina 211 (22.5) 99 (10.7) <0.01
Prior angioplasty 101 (10.8) 74 (8.0) 0.04
Prior CABG 58 (6.2) 31 (3.4) <0.01
Prior peripheral arterial disease 19 (2.0) 11 (1.2) 0.16
Prior CHF 43 (4.6) 12 (1.3) <0.01
Prior arrhythmia 83 (8.9) 49 (5.3) <0.03
Prior CAD 194 (20.7) 121 (13.14) <0.01
Prior tachycardia 19 (1.9) 10 (1.1) 0.14
Data are number (%) except where otherwise specified.
CABG, coronary artery bypass graft; CAD, coronary artery disease; CHF, congestive heart failure; MI, myocardial infarction.
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hypertension, dyslipidaemia and family history of CAD.
Moreover, the proportion of patients having prior
medical conditions was higher among the traditional
approach group.
Cost and length of stay analysis
In the traditional approach (n=938), <1% (n=9) were
allocated to the low-risk category, 62% (n=585) were
classed as intermediate risk, 36% (n=336) as high risk
and 0.8% (n=8) of patients left against medical advice
(table 2). None of the nine low-risk patients had EST,
and they spent fewer hours in hospital than
intermediate-risk and high-risk patients. Among patients
in the intermediate-risk group, those who had an EST
incurred lower costs than those who did not ($1863 vs
$2974). The difference arose as 88% of patients having
an EST were discharged from hospital following a nega-
tive EST result. In contrast, 128 (56%) of 229 patients
who did not perform an EST were admitted to the ward
for further investigation, which incurred higher costs.
Five patients died, with three having a cardiovascular
cause of death during their hospital stay and two dying
within 6 days of hospital discharge from non-
cardiovascular causes.
Of the 921 patients available for the Brisbane proto-
col, 18% (n=169) were classed as ‘Brisbane protocol-low’
risk, 55% (n=514) as ‘Brisbane protocol-intermediate’
risk, 25% (n=230) as high risk and 0.9% (n=8) of
patients left against medical advice (table 3). Overall,
50% of patients managed by the Brisbane protocol per-
formed an EST. In comparison, 38% of the cohort in
the traditional approach performed an EST. In the
Table 2 Summary statistics on cost and length of stay for the traditional approach
Risk stratification
Number of patients
n=938 (%)
Cost Median
(25–75th centile)
Hours in hospital
Median (25–75th centile)
Low 9 (1.0) $A1636 ($A1155–$A3592) 11.5 (9.5–31.5)
Intermediate 585 (62.4) $A1961 ($A1466–$A3780) 24.6 (9.9–35.1)
EST 356 $A1863 ($A1493–$A2528) 23.8 (10.2–28.7)
Negative 312 $A1799 ($A1477–2243) 20.4 (10.1–27.8)
Equivocal 26 $A2700 ($A1904–4277) 29.7 (26.0–52.1)
Positive 18 $A7113 ($A5419–$A10 348) 61.8 (34.5–130.5)
No EST 229 $A2974 ($A1294–$A7163) 27.6 (8.5–76.7)
Send home 101 $A1285 ($A1094–$A1626) 8.4 (6.2–10.4)
Admit to ward 128 $A6642 ($A3975–$A9085) 71.0 (34.2–126.7)
High 336 (35.8) $A6743 ($A2755–$A12 509) 73.2 (27.5–143.7)
Alive with treatment 331 $A6705 ($A2755–$A12 495) 72.3 (27.0–142.4)
Died <30 days 5 $A9340 ($A3177–$A38 594) 146.4 (83.4–426.5)
Left against medical advice 8 (0.8) $A1461 ($A1057–$A2232) 14.1 (5.5–25.0)
EST, exercise stress test.
Table 3 Summary statistics on cost and length of stay for the Brisbane protocol
Risk stratification
Number of patients
n=921 (%)
Cost Median
(25–75th centile)
Hours in hospital
Median (25–75th centile)
Brisbane protocol-low 169 (18.3) $A1061 ($A901–$A1374) 5.3 (4.3–7.0)
EST 39 $A1563 ($A1042–$A1807) 7.7 (6.5–24.5)
Negative 37 $A1515 ($A1028–$A1706) 7.7 (6.4–10.4)
Equivocal 2 $A3897 28.9
No EST 136 $A1009 ($A820–$A1233) 4.8 (4.2–5.9)
Send home 129 $A989 ($A818–$A1198) 4.8 (4.2–5.7)
Admit to ward 7 $A2858 ($A1028–$A9777) 23.0 (4.8–127.5)
Brisbane protocol-intermediate 514 (55.8) $A1485 ($A1095–$A2086) 7.9 (6.3–15.2)
EST 420 $A1449 ($A1085–$A1759) 7.7 (6.3–10.1)
Negative 351 $A1366 ($A1063–$A1618) 7.3 (6.1–8.8)
Equivocal 47 $A3111 ($A1770–$A5492) 26.8 (9.6–34.3)
Positive 22 $A6056 ($A4065–$A6765) 46.3 (28.9–52)
No EST 94 $A2840 ($A1143–$A7838) 27.5 (6.2–53.4)
Send home 42 $A1116 ($A942–$A1436) 621 (4.7–8.5)
Admit to ward 52 $A6856 ($A4178–$A11 238) 50.8 (29.5–80.0)
High 230 (25.0) $A5626 ($A2655–$A9545) 43.7 (24.4–74.8)
Left against medical advice 8 (0.9) $A1272 ($A1168–$A1737) 6.0 (5.2–7.3)
EST, exercise stress test.
Cheng Q, et al. BMJ Open 2016;6:e009746. doi:10.1136/bmjopen-2015-009746 7
Open Access
group.bmj.com on February 28, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
‘Brisbane protocol-low’-risk group, 39 of 169 patients
performed an EST, while 420 of 514 in the ‘Brisbane
protocol-intermediate’-risk group had an EST. Patients
in the ‘Brisbane protocol-low’-risk group incurred fewer
costs and spent fewer hours in hospital than those in the
‘Brisbane protocol-intermediate’-risk group ($1061 vs
$1485; 5.3 h vs 7.9 h). Patients who left against medical
advice incurred the least cost. No one died within
30 days after discharge in the Brisbane protocol cohort.
In table 4, costs and hospital length of stay according
to admission category were compared between the trad-
itional approach group and the Brisbane protocol
group. Nearly 83% of patients assessed by the Brisbane
protocol were admitted to ED only and ED short stay
unit compared with 66% in the traditional approach
group. Total hospital length of stay was shorter with the
Brisbane protocol. Fewer patients in the Brisbane proto-
col group received inpatient care (17% vs 33%), and
they had generally shorter lengths of stay, median 45 vs
52.5 h. The median cost and length of stay when consid-
ering all patients were lower in the Brisbane protocol
cohort.
Percentage of patients discharged within 4 h from ED
The percentage of patients who were discharged from
ED within 4 h by risk stratification is shown in table 5,
and we give the results before and after patient
characteristics in the traditional approach were adjusted
in an attempt to make the two cohorts more compar-
able. As the Brisbane protocol only further stratified
low-risk and intermediate-risk groups, the proportion of
patients discharged from ED in high-risk group was
similar between two approaches. Although the Brisbane
protocol failed to achieve NEAT and discharged, admit-
ted or transferred 62% of ED patients from all risk
groups within 4 h, it enabled physicians to discharge a
higher proportion of patients within 4 h in low-risk and
intermediate-risk groups than the traditional approach
(72% vs 51%).
Decision tree model outputs
The expected costs and length of stay in hospital of the
two approaches from the decision tree model are shown
in table 6. The average patient managed by the Brisbane
protocol cost $1229 less, and 26 h in hospital was saved
compared to the traditional approach. These differences
are shown by the probabilistic sensitivity analysis and are
plotted in figure 4.
Figure 5 provides the proportion of the 10 000 resam-
ples where the Brisbane protocol resulted in a lower cost
or shorter stays for the average patient. When only cost
was taken into consideration, the Brisbane protocol had
a 78% probability of incurring fewer costs. When shorter
length of stay was the decision criteria, there was a 79%
probability the Brisbane protocol is optimal.
Ta
b
le
4
C
os
ts
an
d
ho
sp
ita
ll
en
gt
h
of
st
ay
of
E
D
pa
tie
nt
s
w
ith
ch
es
t
pa
in
ac
co
rd
in
g
to
ad
m
is
si
on
ca
te
go
ry
(w
ith
ou
t
hi
gh
-r
is
k
gr
ou
p
as
th
e
B
ris
ba
ne
pr
ot
oc
ol
ta
rg
et
ed
lo
w
-r
is
k/
in
te
rm
ed
ia
te
-r
is
k
pa
tie
nt
s)
Tr
ad
iti
o
n
al
ap
p
ro
ac
h
B
ri
sb
an
e
p
ro
to
co
l
A
d
m
is
si
o
n
ca
te
g
o
ry
N
u
m
b
er
o
f
p
at
ie
n
ts
(%
)
C
o
st
M
ed
ia
n
(2
5–
75
th
ce
n
til
e)
H
o
u
rs
in
h
o
sp
ita
l
M
ed
ia
n
(2
5–
75
th
ce
n
til
e)
N
u
m
b
er
o
f
p
at
ie
n
ts
(%
)
C
o
st
M
ed
ia
n
(2
5–
75
th
ce
n
til
e)
H
o
u
rs
in
h
o
sp
ita
l
M
ed
ia
n
(2
5–
75
th
ce
n
til
e)
E
D
on
ly
28
(4
.7
)
$A
88
2
($
A
86
5–
$A
10
27
)
5.
6
(4
.1
–
8.
4)
78
(1
1.
3)
$A
97
6
($
A
91
9–
$A
10
68
)
4.
7
(3
.9
–
5.
8)
E
D
sh
or
t
st
ay
un
it
36
8
(6
1.
1)
$A
16
19
($
A
13
93
–
$A
20
24
)
11
.3
(9
.3
–
25
.5
)
49
6
(7
1.
8)
$A
13
15
($
A
10
48
–
$A
16
05
)
7.
0
(5
.8
–
8.
6)
In
pa
tie
nt
w
ar
d
20
1
(3
3.
4)
$A
56
73
($
A
33
31
–
$A
83
01
)
52
.5
(3
0.
8–
11
6.
3)
11
6
(1
6.
8)
$A
58
52
($
A
31
93
–
$A
84
67
)
45
.0
(2
8.
5–
74
.0
)
T
ra
ns
fe
rr
ed
5
(0
.8
)
$A
10
71
($
A
99
9–
$A
12
99
)
44
.8
(1
8.
8–
70
.6
)
1
(0
.1
)
$A
10
28
4.
1
A
ll
ca
te
go
rie
s
60
2
(1
00
)
$A
19
59
($
A
14
55
–
$A
37
26
)
24
.3
(9
.9
–
34
.1
)
69
1
(1
00
)
$A
13
63
($
A
10
37
–
$A
18
03
)
7.
2
(5
.7
–
10
.4
)
E
D
,e
m
er
ge
nc
y
de
pa
rt
m
en
t.
8 Cheng Q, et al. BMJ Open 2016;6:e009746. doi:10.1136/bmjopen-2015-009746
Open Access
group.bmj.com on February 28, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
DISCUSSION
We report the first study of the potential health services
gain of adopting an ADP into routine practice in the
Australian healthcare setting. Some advantages of ADP
for assessing patients presenting to ED with chest pain
have previously been demonstrated.6–8 This analysis used
data collected over two different periods and included it
in a decision tree model to compare cost and length of
stay between the traditional assessment approach and
the Brisbane protocol. We demonstrated the economic
benefits of applying the Brisbane protocol in a hospital
setting.
The Brisbane protocol for the assessment of emer-
gency patients with possible cardiac chest pain may have
considerable benefits to patients with early notification
about the underlying cause of their symptoms, and early
discharge of those without a cardiac diagnosis. Adopting
the Brisbane protocol could also assist in meeting NEAT
targets. About 70% of non-high-risk patients could be
assessed rapidly for ACS and discharged from ED within
4 h under the Brisbane protocol. In the hospital, the
average ED length of stay fell from 289 min between
2008 and 2010 to 243 min between 2011 and 2014, the
period when the Brisbane protocol was implemented.
Whether this observed saving of 45 min per patient was
caused by the Brisbane protocol cannot be known for
certain due to the non-randomised study design. The
overall capacity released for the hospital was substantial,
with a reduction in the expected assessment period
from 42 to 16 h for all non-high-risk patients. The reduc-
tion in need for lengthy admission supported same-day
discharge for many patients. The economics of this in
terms of time missed from work, family and social
activities is hard to quantify; however, early discharge
home for patients is likely to have had a positive effect
on patient satisfaction.
The Brisbane protocol identified a large proportion of
patients as low risk. This is a significant increase by com-
parison with the current National Heart Foundation and
Cardiac Society of Australia and New Zealand
Guidelines risk stratification process and is an
equivalent-sized low-risk cohort in comparison with
other risk scores such as TIMI and GRACE scores when
used for ED patient assessment. The true reduction in
need for EST testing in this cohort may have larger
system effects in terms of improving access for other
patients requiring this cardiac investigation. This was not
assessed in the study. Compared to other ADP
approaches, the Brisbane protocol has its strength that it
incorporates both AMI and UAP. There are other
approaches used to identify those at risk of AMI
alone,19 20 but these ignore the increased short-term to
medium-term risk of recurrent ischaemic events in those
with underlying CAD and UAP. Moreover, the tools
required for implementation of the Brisbane protocol
do not differ from what is currently widely available.
Troponin assays and ECGs will continue to be per-
formed, and the risk stratification process can be easily
adopted in other hospitals. We believe that the uptake of
this strategy into clinical practice will be rapid.
Other economic analysis of applying ADP to assess
patients with chest pain also shows evidence for reduced
hospitalisation stay and lower costs. Asher et al21 in Israel
examined the clinical outcomes and cost-effectiveness of
an ADP using contemporary technology versus routine
care and found that an ADP could save time and
resources. There was a slight decrease in total costs
when patients were treated ADP, but the difference was
not significant. Compared with their comparative pro-
spective study, our study has strengths in that we com-
bined comparative study with an economic decision
model. By taking account of the probability of being
classified as low or intermediate risk and the probability
of having an EST, the decision tree model demonstrates
the expected cost and length of stay for a patient who
presents to ED with chest pain. In addition, we con-
ducted probabilistic sensitivity analysis to account for
parameter uncertainty surrounding cost and length of
stay. The Brisbane protocol has shown a high probability
Table 6 Expected costs and length of stay in hospital per patient for the traditional approach and the Brisbane protocol
(without high-risk group as the Brisbane protocol targeted low-risk/intermediate-risk patients)
Expected cost
(95% CI)
Expected length
of stay (95% CI)
Incremental
cost (95% CI)
Incremental length
of stay (95% CI)
Traditional
approach
$A3454 ($A1438–
$A7159)
42 h (8–153 h)
Brisbane protocol $A2225 ($A1282–
$A3609)
16 h (7–32 h) −$A1229
(−$A5122 to
$A1266)
−26 h (−136 to
14 h)
Table 5 Percentage of patients discharged from ED
within 4 h by risk stratification before and after baseline
characteristics were adjusted
Traditional
approach
(not
adjusted), %
Traditional
approach
(adjusted),
%
Brisbane
protocol
(%)
High risk 26.0 30.1 30.2
Low and
intermediate risk
46.1 50.6 72.3
ED, emergency department.
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of being optimal compared with the traditional
approach.
The limitations of this analysis should be acknowl-
edged. First, in both cohorts, patients were recruited
between 8:00 and 17:00 due to the significant cost of
out-of-hour recruitment. The potential impact of enrol-
ling patients for a portion of the day is not known as we
are unable to quantify any possible effect without data
from out-of-hour patients. However, we do not believe
the impact of predominantly in-hour recruitment will
have a significant impact on the findings. One of our
previous studies examined whether in-hour recruitment
biased the findings.22 We found that individuals
recruited outside work hours did not differ from those
recruited within work hours in terms of demographics
and medical history. Second, ideally a pragmatic parallel
multicentre randomised controlled trial would be done,
but this would cost millions of dollars and will take time
to organise. With the observational design, we cannot be
sure that the Brisbane protocol contributed to the differ-
ences in the outcomes. The results of the adjustment
(table 5) provide some evidence of an effect arising
from the Brisbane protocol. When the two cohorts were
adjusted for the baseline variables, the proportion of
patients discharged from ED within 4 h did change, but
not dramatically. Despite these limitations, the improve-
ment in cost and length of stay outcomes is plausible,
and the purpose of this study is to provide data that con-
tribute to a decision being made, rather than perfectly
estimating the size of an effect. As this study is focused
on the health economic outcomes of the Brisbane
protocol, it does not report the detailed clinical out-
comes of patients managed according to the traditional
diagnostic approach and the Brisbane protocol.
CONCLUSION
The Brisbane protocol may be a cost-saving change to
services for the assessment of ED patients with possible
ACS. Patients and the EDs that manage them might
benefit from this system of care.
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